Advisory Committees

January 15, 2013: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Agenda

Food and Drug Administration
Cellular, Tissue and Gene Therapies Advisory Committee
Meeting #57
January 15, 2013
National Institutes of Health, Building 29B, Conference Room C

Open Session

2:00 p.m. (EST)Welcome and Administrative Remarks
Evan Snyder, M.D., Ph.D., Chair

Roll Call and Conflict of Interest Statement
Gail Dapolito, Designated Federal Officer
Center for Drug Evaluation and Research (CDER)
2:05Overview Research Programs
Office of Biotechnology Products (OBP), CDER
Steven Kozlowski, M.D., Director, OBP
Edward Max, M.D., Ph.D., Associate Director
for Research, Division of Therapeutic Proteins, OBP
2:30Division of Therapeutic Proteins (DTP)
Amy Rosenberg, M.D., Director, DTP
Research Program Summaries
2:50Laboratory of Immunology (LI)
Danielle Verthelyi, M.D., Ph.D., Chief, LI
3:30Open Public Hearing
4:30Closed Session
5:15 p.m.Adjourn

Page Last Updated: 08/14/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English